Donald W. Reynolds National Center For Business Journalism

Two Minute Tips

Health Care

The economics of retirement and health care are a rich source of personal finance stories. (Image by "Tookapic" via Pixabay, CC0 Public Domain)

Health care costs and retirees

Two key surveys recently noted a continuing downward trend in retirement readiness among workers and retirees: The Center for Retirement Research at Boston College reports that 52 percent of households are “at

Millennials and money: Healthcare trends

With a purchasing power of over $200 billion annually, millennials are more than economic influencers: They drive trends based on their spending. The healthcare industry is no exception. Here are

Doctor holding a newborn baby

The cost of fertility treatment

According to data published by the National Health Statistics Reports in 2014, 12 percent of women aged 15-44 or their husbands or partners have ever used infertility services. However, treatments

How to localize pharmaceutical stories

The United States pharmaceutical industry is a global leader, responsible for over 40 percent of the industry’s worldwide revenue. And more Americans than ever are taking prescription drugs.   A

Reynolds reads: 5 questions with Adam Tanner

Adam Tanner’s newest book, “Our Bodies, Our Data: How Companies Make Billions Selling Our Medical Records” was released in January. Tanner served as a Reuters news agency correspondent from 1995 to 2011, with key positions

Barlett and Steele Awards

How they did it: “OxyContin’s 12-Hour Problem”

Earlier this month the 2016 Barlett & Steele bronze award was given to “OxyContin’s 12-Hour Problem,” the Los Angeles Times’ investigation into how America’s bestselling prescriptive painkiller helped fuel a nationwide opioid epidemic.

new health and wealth data

New health and wealth data: Insights for journalists

New evidence shows that the wealthiest Americans outlive their poorer counterparts, and it’s sparked new conversations about the interplay between wealth, poverty and health. Here is what you should know

drugs

Reporting on Big Pharma

Former pharmaceutical executive Martin Shkreli made another return to the news cycle this month, first at a controversial Congressional hearing and then for a lawsuit Shkreli is partied to. Shkreli, dubbed

Get Two Minute Tips For Business Journalism Delivered To Your Email Every Tuesday

Two Minute Tips

Every Tuesday we send out a quick-read email with tips for business journalism. Sign up now and get one Tuesday.